Copyright Reports & Markets. All rights reserved.

Global Human Herpersvirus 5 (HHV-5) Drug Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Human Herpersvirus 5 (HHV-5) Drug Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Ganciclovir
      • 1.4.3 Valerian Gilivir Drugs
      • 1.4.4 Acyclovir Drugs
      • 1.4.5 Valacyclovir Drugs
      • 1.4.6 Foscarnet Sodium Drugs
    • 1.5 Market by Application
      • 1.5.1 Global Human Herpersvirus 5 (HHV-5) Drug Market Share by Application (2014-2025)
      • 1.5.2 Immunodeficiency Crowd
      • 1.5.3 Organ Transplant Crowd
      • 1.5.4 CMV Herpes Crowd
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Human Herpersvirus 5 (HHV-5) Drug Market Size
    • 2.2 Human Herpersvirus 5 (HHV-5) Drug Growth Trends by Regions
      • 2.2.1 Human Herpersvirus 5 (HHV-5) Drug Market Size by Regions (2014-2025)
      • 2.2.2 Human Herpersvirus 5 (HHV-5) Drug Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Human Herpersvirus 5 (HHV-5) Drug Market Size by Manufacturers
      • 3.1.1 Global Human Herpersvirus 5 (HHV-5) Drug Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Human Herpersvirus 5 (HHV-5) Drug Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Human Herpersvirus 5 (HHV-5) Drug Market Concentration Ratio (CR5 and HHI)
    • 3.2 Human Herpersvirus 5 (HHV-5) Drug Key Players Head office and Area Served
    • 3.3 Key Players Human Herpersvirus 5 (HHV-5) Drug Product/Solution/Service
    • 3.4 Date of Enter into Human Herpersvirus 5 (HHV-5) Drug Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Human Herpersvirus 5 (HHV-5) Drug Market Size by Type (2014-2019)
    • 4.2 Global Human Herpersvirus 5 (HHV-5) Drug Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Human Herpersvirus 5 (HHV-5) Drug Market Size (2014-2019)
    • 5.2 Human Herpersvirus 5 (HHV-5) Drug Key Players in United States
    • 5.3 United States Human Herpersvirus 5 (HHV-5) Drug Market Size by Type
    • 5.4 United States Human Herpersvirus 5 (HHV-5) Drug Market Size by Application

    6 Europe

    • 6.1 Europe Human Herpersvirus 5 (HHV-5) Drug Market Size (2014-2019)
    • 6.2 Human Herpersvirus 5 (HHV-5) Drug Key Players in Europe
    • 6.3 Europe Human Herpersvirus 5 (HHV-5) Drug Market Size by Type
    • 6.4 Europe Human Herpersvirus 5 (HHV-5) Drug Market Size by Application

    7 China

    • 7.1 China Human Herpersvirus 5 (HHV-5) Drug Market Size (2014-2019)
    • 7.2 Human Herpersvirus 5 (HHV-5) Drug Key Players in China
    • 7.3 China Human Herpersvirus 5 (HHV-5) Drug Market Size by Type
    • 7.4 China Human Herpersvirus 5 (HHV-5) Drug Market Size by Application

    8 Japan

    • 8.1 Japan Human Herpersvirus 5 (HHV-5) Drug Market Size (2014-2019)
    • 8.2 Human Herpersvirus 5 (HHV-5) Drug Key Players in Japan
    • 8.3 Japan Human Herpersvirus 5 (HHV-5) Drug Market Size by Type
    • 8.4 Japan Human Herpersvirus 5 (HHV-5) Drug Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Human Herpersvirus 5 (HHV-5) Drug Market Size (2014-2019)
    • 9.2 Human Herpersvirus 5 (HHV-5) Drug Key Players in Southeast Asia
    • 9.3 Southeast Asia Human Herpersvirus 5 (HHV-5) Drug Market Size by Type
    • 9.4 Southeast Asia Human Herpersvirus 5 (HHV-5) Drug Market Size by Application

    10 India

    • 10.1 India Human Herpersvirus 5 (HHV-5) Drug Market Size (2014-2019)
    • 10.2 Human Herpersvirus 5 (HHV-5) Drug Key Players in India
    • 10.3 India Human Herpersvirus 5 (HHV-5) Drug Market Size by Type
    • 10.4 India Human Herpersvirus 5 (HHV-5) Drug Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Human Herpersvirus 5 (HHV-5) Drug Market Size (2014-2019)
    • 11.2 Human Herpersvirus 5 (HHV-5) Drug Key Players in Central & South America
    • 11.3 Central & South America Human Herpersvirus 5 (HHV-5) Drug Market Size by Type
    • 11.4 Central & South America Human Herpersvirus 5 (HHV-5) Drug Market Size by Application

    12 International Players Profiles

    • 12.1 Roche
      • 12.1.1 Roche Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Human Herpersvirus 5 (HHV-5) Drug Introduction
      • 12.1.4 Roche Revenue in Human Herpersvirus 5 (HHV-5) Drug Business (2014-2019)
      • 12.1.5 Roche Recent Development
    • 12.2 Livzon Pharmaceuticals
      • 12.2.1 Livzon Pharmaceuticals Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Human Herpersvirus 5 (HHV-5) Drug Introduction
      • 12.2.4 Livzon Pharmaceuticals Revenue in Human Herpersvirus 5 (HHV-5) Drug Business (2014-2019)
      • 12.2.5 Livzon Pharmaceuticals Recent Development
    • 12.3 Sichuan Cologne Pharmaceutical
      • 12.3.1 Sichuan Cologne Pharmaceutical Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Human Herpersvirus 5 (HHV-5) Drug Introduction
      • 12.3.4 Sichuan Cologne Pharmaceutical Revenue in Human Herpersvirus 5 (HHV-5) Drug Business (2014-2019)
      • 12.3.5 Sichuan Cologne Pharmaceutical Recent Development
    • 12.4 Hubei Branch benefits medicine
      • 12.4.1 Hubei Branch benefits medicine Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Human Herpersvirus 5 (HHV-5) Drug Introduction
      • 12.4.4 Hubei Branch benefits medicine Revenue in Human Herpersvirus 5 (HHV-5) Drug Business (2014-2019)
      • 12.4.5 Hubei Branch benefits medicine Recent Development
    • 12.5 GlaxoSmithKline
      • 12.5.1 GlaxoSmithKline Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Human Herpersvirus 5 (HHV-5) Drug Introduction
      • 12.5.4 GlaxoSmithKline Revenue in Human Herpersvirus 5 (HHV-5) Drug Business (2014-2019)
      • 12.5.5 GlaxoSmithKline Recent Development
    • 12.6 Upright and clear
      • 12.6.1 Upright and clear Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Human Herpersvirus 5 (HHV-5) Drug Introduction
      • 12.6.4 Upright and clear Revenue in Human Herpersvirus 5 (HHV-5) Drug Business (2014-2019)
      • 12.6.5 Upright and clear Recent Development
    • 12.7 Chongqing Winbond (acquisition of Sichuan Mingxin)
      • 12.7.1 Chongqing Winbond (acquisition of Sichuan Mingxin) Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Human Herpersvirus 5 (HHV-5) Drug Introduction
      • 12.7.4 Chongqing Winbond (acquisition of Sichuan Mingxin) Revenue in Human Herpersvirus 5 (HHV-5) Drug Business (2014-2019)
      • 12.7.5 Chongqing Winbond (acquisition of Sichuan Mingxin) Recent Development
    • 12.8 Haikou Kellett
      • 12.8.1 Haikou Kellett Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Human Herpersvirus 5 (HHV-5) Drug Introduction
      • 12.8.4 Haikou Kellett Revenue in Human Herpersvirus 5 (HHV-5) Drug Business (2014-2019)
      • 12.8.5 Haikou Kellett Recent Development
    • 12.9 On the drug new Asia
      • 12.9.1 On the drug new Asia Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Human Herpersvirus 5 (HHV-5) Drug Introduction
      • 12.9.4 On the drug new Asia Revenue in Human Herpersvirus 5 (HHV-5) Drug Business (2014-2019)
      • 12.9.5 On the drug new Asia Recent Development
    • 12.10 Chongqing Fu'an Pharmaceutical
      • 12.10.1 Chongqing Fu'an Pharmaceutical Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 Human Herpersvirus 5 (HHV-5) Drug Introduction
      • 12.10.4 Chongqing Fu'an Pharmaceutical Revenue in Human Herpersvirus 5 (HHV-5) Drug Business (2014-2019)
      • 12.10.5 Chongqing Fu'an Pharmaceutical Recent Development
    • 12.11 Shandong Luo Xin Pharmaceutical
    • 12.12 Yangtze River Pharmaceutical
    • 12.13 Qianjiang Pharmaceuticals
    • 12.14 Wuhan Hualong

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      In 2018, the global Human Herpersvirus 5 (HHV-5) Drug market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2019-2025.

      This report focuses on the global Human Herpersvirus 5 (HHV-5) Drug status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Human Herpersvirus 5 (HHV-5) Drug development in United States, Europe and China.

      The key players covered in this study
      Roche
      Livzon Pharmaceuticals
      Sichuan Cologne Pharmaceutical
      Hubei Branch benefits medicine
      GlaxoSmithKline
      Upright and clear
      Chongqing Winbond (acquisition of Sichuan Mingxin)
      Haikou Kellett
      On the drug new Asia
      Chongqing Fu'an Pharmaceutical
      Shandong Luo Xin Pharmaceutical
      Yangtze River Pharmaceutical
      Qianjiang Pharmaceuticals
      Wuhan Hualong

      Market segment by Type, the product can be split into
      Ganciclovir
      Valerian Gilivir Drugs
      Acyclovir Drugs
      Valacyclovir Drugs
      Foscarnet Sodium Drugs

      Market segment by Application, split into
      Immunodeficiency Crowd
      Organ Transplant Crowd
      CMV Herpes Crowd

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Human Herpersvirus 5 (HHV-5) Drug status, future forecast, growth opportunity, key market and key players.
      To present the Human Herpersvirus 5 (HHV-5) Drug development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Human Herpersvirus 5 (HHV-5) Drug are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now